Regulus Therapeutics Inc. (RGLS)
1.95
0.20 (11.43%)
At close: Apr 02, 2025, 3:59 PM
1.85
-4.72%
After-hours: Apr 02, 2025, 07:54 PM EDT
Regulus Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
7.5
Upside
285.60
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Wells Fargo | Buy | Upgrades | 3 6 | 208.48% | Mar 27, 2025 | |
| Canaccord Genuity | Buy | Maintains | 28 28 | 1339.59% | Mar 17, 2025 | |
| HC Wainwright & Co. | Buy | Reiterates | 10 10 | 414.14% | Mar 14, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.